Want to join the conversation?
Biofuels company $GEVO reported a wider 2Q16 net loss due to a jump in other expenses. The company reported net loss of $21.49MM, or $0.44 per share, compared with net loss of $14.37MM, or $1.10 per share a year ago. Loss per share narrowed due to a higher share count.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?